Occidental Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.51M | Buy |
40,670
+551
| +1% | +$61.1K | 0.62% | 50 |
|
2025
Q1 | $4.5M | Buy |
40,119
+1,503
| +4% | +$168K | 0.68% | 41 |
|
2024
Q4 | $3.57M | Buy |
38,616
+3,980
| +11% | +$368K | 0.56% | 53 |
|
2024
Q3 | $2.9M | Buy |
34,636
+2,960
| +9% | +$248K | 0.47% | 61 |
|
2024
Q2 | $2.17M | Buy |
31,676
+3,101
| +11% | +$213K | 0.38% | 75 |
|
2024
Q1 | $2.09M | Buy |
+28,575
| New | +$2.09M | 0.39% | 73 |
|
2021
Q1 | – | Sell |
-18,095
| Closed | -$1.05M | – | 191 |
|
2020
Q4 | $1.05M | Buy |
18,095
+1,487
| +9% | +$86.6K | 0.35% | 83 |
|
2020
Q3 | $1.05M | Buy |
16,608
+354
| +2% | +$22.4K | 0.44% | 55 |
|
2020
Q2 | $1.25M | Buy |
16,254
+501
| +3% | +$38.6K | 0.55% | 37 |
|
2020
Q1 | $1.18M | Buy |
15,753
+2,835
| +22% | +$212K | 0.59% | 32 |
|
2019
Q4 | $839K | Buy |
12,918
+429
| +3% | +$27.9K | 0.34% | 83 |
|
2019
Q3 | $792K | Buy |
12,489
+1,860
| +17% | +$118K | 0.33% | 71 |
|
2019
Q2 | $718K | Buy |
10,629
+2,157
| +25% | +$146K | 0.32% | 69 |
|
2019
Q1 | $551K | Buy |
8,472
+1,732
| +26% | +$113K | 0.26% | 79 |
|
2018
Q4 | $422K | Buy |
6,740
+460
| +7% | +$28.8K | 0.24% | 84 |
|
2018
Q3 | $485K | Buy |
6,280
+289
| +5% | +$22.3K | 0.24% | 79 |
|
2018
Q2 | $424K | Buy |
5,991
+202
| +3% | +$14.3K | 0.23% | 88 |
|
2018
Q1 | $436K | Sell |
5,789
-40
| -0.7% | -$3.01K | 0.24% | 75 |
|
2017
Q4 | $418K | Buy |
5,829
+236
| +4% | +$16.9K | 0.22% | 84 |
|
2017
Q3 | $453K | Buy |
5,593
+146
| +3% | +$11.8K | 0.25% | 68 |
|
2017
Q2 | $386K | Buy |
5,447
+137
| +3% | +$9.71K | 0.23% | 76 |
|
2017
Q1 | $361K | Buy |
5,310
+522
| +11% | +$35.5K | 0.24% | 76 |
|
2016
Q4 | $343K | Buy |
+4,788
| New | +$343K | 0.25% | 77 |
|